Oral microbiota promotion for immune system associated inflammations
First Claim
1. A method of selectively promoting a desired oral microbiota to treat an inflammation condition caused by an allergic reaction in a subject in need of such treatment comprising:
- providing a preformulated prebiotic edible composition comprising an amino acid containing ingredient comprising L-arginine, the L-arginine configured to be present at a concentration of greater than about 0.1 wt % substantially comprised of separate individual molecules of L-arginine within an oral cavity of the subject;
substantially removing a biofilm from surfaces comprising the oral cavity, the removing comprising exposing the biofilm to a biofilm degrading enzyme;
wherein at least one of during and following removal of the biofilm, the composition is contained and at least partially dissolved within an oral cavity of the subject for a period of at least from about 60 seconds to about 3600 seconds on a daily basis comprising at least one day in an effective amount to selectively promote an increased concentration of selected oral microbiota to thereby treat the inflammation condition, the selectively promoted microbiota comprising Veillonella and Streptococcus.
1 Assignment
0 Petitions
Accused Products
Abstract
A method of promoting a desired oral microbiota to treat an inflammation condition related to an allergic reaction in a subject in need of such treatment including providing a preformulated edible composition including an amino acid containing ingredient comprising L-arginine, the composition configured to be present as individual molecules of L-arginine within an oral cavity of the subject; removing a biofilm from surfaces within an oral cavity including exposing the biofilm to a biofilm degrading enzyme; wherein during or following removal of the biofilm, the composition is provided contained and at least partially dissolved within an oral cavity of the subject for a period of at least from about 30 seconds to about an hour on a daily basis comprising at least one day to promote an increased concentration of selected oral microbiota, the selected microbiota including Veillonella and Streptococcus.
-
Citations
25 Claims
-
1. A method of selectively promoting a desired oral microbiota to treat an inflammation condition caused by an allergic reaction in a subject in need of such treatment comprising:
-
providing a preformulated prebiotic edible composition comprising an amino acid containing ingredient comprising L-arginine, the L-arginine configured to be present at a concentration of greater than about 0.1 wt % substantially comprised of separate individual molecules of L-arginine within an oral cavity of the subject; substantially removing a biofilm from surfaces comprising the oral cavity, the removing comprising exposing the biofilm to a biofilm degrading enzyme; wherein at least one of during and following removal of the biofilm, the composition is contained and at least partially dissolved within an oral cavity of the subject for a period of at least from about 60 seconds to about 3600 seconds on a daily basis comprising at least one day in an effective amount to selectively promote an increased concentration of selected oral microbiota to thereby treat the inflammation condition, the selectively promoted microbiota comprising Veillonella and Streptococcus. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24)
-
-
25. A method of selectively promoting a desired oral microbiota to treat an inflammation condition caused by an allergic reaction in a subject in need of such treatment comprising:
-
providing a preformulated prebiotic edible composition comprising an amino acid containing ingredient comprising L-arginine, the L-arginine configured to be present at a concentration of greater than about 0.1 wt % substantially comprised of separate individual molecules of L-arginine within an oral cavity of the subject; substantially removing a biofilm from surfaces comprising the oral cavity, the removing comprising exposing the biofilm to a biofilm degrading enzyme; wherein following removal of the biofilm, the composition is contained and at least partially dissolved within an oral cavity of the subject for a period of at least from about 60 seconds to about an 3600 seconds on a daily basis comprising at least one day in an effective amount to selectively promote an increased concentration of selected oral microbiota to thereby treat the inflammation condition, the selectively promoted microbiota comprising Veillonella and Streptococcus at a concentration of about 40 percent to about 70 percent with respect to all bacterial species present from a sampled surface comprising the oral cavity.
-
Specification